Actinium Pharmaceuticals, Inc. (ATNM)
1.05
-0.02
(-1.87%)
USD |
NYAM |
Nov 20, 16:00
1.06
+0.01
(+0.95%)
After-Hours: 20:00
Actinium Pharmaceuticals Price to Book Value : 1.343 for Nov. 20, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 20, 2026 | 1.343 |
| November 19, 2026 | 1.368 |
| November 18, 2026 | 1.381 |
| November 17, 2026 | 1.726 |
| November 16, 2026 | 1.906 |
| November 13, 2026 | 2.097 |
| November 12, 2026 | 2.033 |
| November 11, 2026 | 2.033 |
| November 10, 2026 | 2.008 |
| November 09, 2026 | 1.970 |
| November 06, 2026 | 1.829 |
| November 05, 2026 | 1.663 |
| November 04, 2026 | 1.803 |
| November 03, 2026 | 1.790 |
| November 02, 2026 | 1.829 |
| October 30, 2026 | 1.893 |
| October 29, 2026 | 1.957 |
| October 28, 2026 | 1.765 |
| October 27, 2026 | 1.816 |
| October 26, 2026 | 1.790 |
| October 23, 2026 | 1.944 |
| October 22, 2026 | 2.046 |
| October 21, 2026 | 1.765 |
| October 20, 2026 | 1.790 |
| October 19, 2026 | 1.688 |
| Date | Value |
|---|---|
| October 16, 2026 | 1.445 |
| October 15, 2026 | 1.356 |
| October 14, 2026 | 1.246 |
| October 13, 2026 | 1.278 |
| October 12, 2026 | 1.356 |
| October 09, 2026 | 1.407 |
| October 08, 2026 | 1.381 |
| October 07, 2026 | 1.368 |
| October 06, 2026 | 1.420 |
| October 05, 2026 | 1.535 |
| October 02, 2026 | 1.496 |
| October 01, 2026 | 1.471 |
| September 30, 2026 | 1.432 |
| September 29, 2026 | 1.183 |
| September 28, 2026 | 1.224 |
| September 25, 2026 | 1.245 |
| September 24, 2026 | 1.235 |
| September 23, 2026 | 1.224 |
| September 22, 2026 | 1.214 |
| September 21, 2026 | 1.245 |
| September 18, 2026 | 1.266 |
| September 17, 2026 | 1.235 |
| September 16, 2026 | 1.287 |
| September 15, 2026 | 1.297 |
| September 14, 2026 | 1.328 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| ACADIA Pharmaceuticals, Inc. | 2.131 |
| Alnylam Pharmaceuticals, Inc. | 5.343 |
| Anika Therapeutics, Inc. | 1.288 |
| Savara, Inc. | 8.118 |
| Arrowhead Pharmaceuticals, Inc. | 116.18 |
Price to Book Value Related Metrics
| PE Ratio | 3.131 |
| PS Ratio | 0.9396 |
| Price | 1.05 |
| Earnings Yield | 31.94% |
| Market Cap | 33.01M |
| Operating PE Ratio | 3.604 |
| Normalized PE Ratio | 3.131 |